Switch to:

Beam Therapeutics EV-to-EBIT

: -12.41 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Beam Therapeutics's Enterprise Value is $1,158.49 Mil. Beam Therapeutics's EBIT for the trailing twelve months (TTM) ended in Mar. 2020 was $-93.39 Mil. Therefore, Beam Therapeutics's EV-to-EBIT for today is -12.41.

NAS:BEAM' s EV-to-EBIT Range Over the Past 10 Years
Min: -18.71   Med: 0   Max: 0
Current: -12.42

-18.71
0
NAS:BEAM's EV-to-EBIT is ranked lower than
99.99% of the 243 Companies
in the Biotechnology industry.

( Industry Median: 34.10 vs. NAS:BEAM: -12.42 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Beam Therapeutics's Enterprise Value for the quarter that ended in Mar. 2020 was $665.70 Mil. Beam Therapeutics's EBIT for the trailing twelve months (TTM) ended in Mar. 2020 was $-93.39 Mil. Beam Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2020 was -14.03%.


Beam Therapeutics EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
EV-to-EBIT 0.00 0.00 0.00

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-EBIT Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -3.59

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Beam Therapeutics EV-to-EBIT Distribution

* The bar in red indicates where Beam Therapeutics's EV-to-EBIT falls into.



Beam Therapeutics EV-to-EBIT Calculation

Beam Therapeutics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1158.489/-93.386
=-12.41

Beam Therapeutics's current Enterprise Value is $1,158.49 Mil.
Beam Therapeutics's EBIT for the trailing twelve months (TTM) ended in Mar. 2020 was -17.651 (Jun. 2019 ) + -19.649 (Sep. 2019 ) + -27.731 (Dec. 2019 ) + -28.355 (Mar. 2020 ) = $-93.39 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics  (NAS:BEAM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Beam Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2020 ) =EBIT / Enterprise Value (Q: Mar. 2020 )
=-93.386/665.7022
=-14.03 %

Beam Therapeutics's Enterprise Value for the quarter that ended in Mar. 2020 was $665.70 Mil.
Beam Therapeutics's EBIT for the trailing twelve months (TTM) ended in Mar. 2020 was -17.651 (Jun. 2019 ) + -19.649 (Sep. 2019 ) + -27.731 (Dec. 2019 ) + -28.355 (Mar. 2020 ) = $-93.39 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics EV-to-EBIT Related Terms


Beam Therapeutics EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)